Entity Common Stock, Shares Outstanding of IGC Pharma, Inc. from 15 Feb 2011 to 30 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
IGC Pharma, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 15 Feb 2011 to 30 Oct 2025.
  • IGC Pharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 30 Oct 2025 was 92,868,241, a 20% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

IGC Pharma, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 92,868,241 +15,418,867 +20% 30 Oct 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 83,891,586 +8,255,167 +11% 20 Jun 2025 10-K 27 Jun 2025 2025 FY
Q4 2024 79,685,165 +15,950,726 +25% 10 Feb 2025 10-Q 14 Feb 2025 2025 Q3
Q3 2024 77,449,374 +13,714,935 +22% 07 Nov 2024 10-Q 12 Nov 2024 2025 Q2
Q2 2024 75,636,419 +22,558,983 +43% 18 Jun 2024 10-K 24 Jun 2024 2024 FY
Q4 2023 63,734,439 +10,657,003 +20% 12 Feb 2024 10-Q 14 Feb 2024 2024 Q3
Q3 2023 63,734,439 +10,667,003 +20% 07 Nov 2023 10-Q 09 Nov 2023 2024 Q2
Q2 2023 53,077,436 +1,333,083 +2.6% 06 Jul 2023 10-K 07 Jul 2023 2023 FY
Q4 2022 53,077,436 +2,023,419 +4% 01 Feb 2023 10-Q 14 Feb 2023 2023 Q3
Q3 2022 53,067,436 +2,016,419 +4% 19 Oct 2022 10-Q 01 Nov 2022 2023 Q2
Q2 2022 51,744,353 +3,417,080 +7.1% 06 Jun 2022 10-K 23 Jun 2022 2022 FY
Q4 2021 51,054,017 +5,687,694 +13% 31 Jan 2022 10-Q 10 Feb 2022 2022 Q3
Q3 2021 51,051,017 +9,746,652 +24% 18 Oct 2021 10-Q 29 Oct 2021 2022 Q2
Q2 2021 48,327,273 +7,141,143 +17% 07 Jun 2021 10-K 14 Jun 2021 2021 FY
Q4 2020 45,366,323 +6,046,207 +15% 09 Feb 2021 10-Q 16 Feb 2021 2021 Q3
Q3 2020 41,304,365 +1,732,958 +4.4% 11 Nov 2020 10-Q 20 Nov 2020 2021 Q2
Q2 2020 41,186,130 +1,674,723 +4.2% 24 Jun 2020 10-K 13 Jul 2020 2020 FY
Q4 2019 39,320,116 -266,706 -0.67% 23 Jan 2020 10-Q 10 Feb 2020 2020 Q3
Q3 2019 39,571,407 +3,223,638 +8.9% 15 Oct 2019 10-Q 06 Nov 2019 2020 Q2
Q2 2019 39,511,407 +8,482,934 +27% 11 Jun 2019 10-K 14 Jun 2019 2019 FY
Q4 2018 39,586,822 +9,304,769 +31% 31 Jan 2019 10-Q 12 Feb 2019 2019 Q3
Q3 2018 36,347,769 +8,282,497 +30% 09 Oct 2018 10-Q 16 Oct 2018 2019 Q2
Q2 2018 31,028,473 +456,525 +1.5% 15 Jun 2018 10-K 21 Jun 2018 2018 FY
Q4 2017 30,282,053 +2,675,606 +9.7% 31 Jan 2018 10-Q 20 Feb 2018 2018 Q3
Q3 2017 28,065,272 -313,615 -1.1% 13 Nov 2017 10-Q 17 Nov 2017 2018 Q2
Q2 2017 30,571,948 +7,235,750 +31% 25 Jun 2017 10-K 14 Jul 2017 2017 FY
Q4 2016 27,606,447 +9,639,511 +54% 30 Jan 2017 10-Q 21 Feb 2017 2017 Q3
Q3 2016 28,378,887 +12,038,644 +74% 08 Nov 2016 10-Q 21 Nov 2016 2017 Q2
Q2 2016 23,336,198 +8,475,909 +57% 25 Jun 2016 10-K 14 Jul 2016 2016 FY
Q4 2015 17,966,936 +2,924,092 +19% 09 Feb 2016 10-Q 16 Feb 2016 2016 Q3
Q3 2015 16,340,243 +2,544,377 +18% 03 Nov 2015 10-Q 13 Nov 2015 2016 Q2
Q2 2015 14,860,289 +3,480,379 +31% 25 Jun 2015 10-K 14 Jul 2015 2015 FY
Q4 2014 15,042,844 +7,061,925 +88% 01 Feb 2015 10-Q 12 Feb 2015 2015 Q3
Q3 2014 13,795,866 +6,314,440 +84% 03 Nov 2014 10-Q 13 Nov 2014 2015 Q2
Q2 2014 11,379,910 +4,399,812 +63% 25 Jun 2014 10-K 15 Jul 2014 2014 FY
Q4 2013 7,980,919 -52,080,818 -87% 31 Dec 2013 10-Q 14 Feb 2014 2013 Q3
Q3 2013 7,481,426 -52,580,311 -88% 30 Sep 2013 10-Q 08 Nov 2013 2013 Q2
Q2 2013 6,980,098 -53,081,639 -88% 25 Jun 2013 10-K 15 Jul 2014 2013 FY
Q4 2012 60,061,737 15 Dec 2012 10-Q 13 Feb 2013 2012 Q3
Q3 2012 60,061,737 +39,101,304 +187% 15 Oct 2012 10-Q 14 Nov 2012 2012 Q2
Q2 2012 60,061,737 +39,101,304 +187% 25 Jun 2012 10-K 16 Jul 2012 2011 FY
Q3 2011 20,960,433 14 Nov 2011 10-Q 18 Nov 2011 2011 Q2
Q2 2011 20,960,433 08 Aug 2011 10-Q 18 Aug 2011 2011 Q1
Q1 2011 52,460,433 15 Feb 2011 10-Q 16 Feb 2012 2011 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.